Diplomat Specialty Pharmacy® and Diplomat Specialty Infusion Group® are joining the Optum® family.

To learn more about what this means for you, visit our FAQ pages:

Specialty Pharmacy FAQ  •  Infusion Pharmacy FAQ

VPRIV®

VPRIV (velaglucerase alfa for injection)

FDA INDICATION: Type 1 Gaucher disease. Package Insert

DISTRIBUTOR: Shire

ROUTE OF ADMINISTRATION: Intravenous

FORM: Lyophilized

DOSAGE AND ADMINISTRATION: 
Patients naive to enzyme replacement therapy: 60 Units/kg every other week.
Patients being treated with stable imiglucerase dosages for Gaucher disease can switch to VPRIV at previous imiglucerase dose two weeks after their last imiglucerase dose.

HOW SUPPLIED: 400 units, single-use vials.

DILUENT: 0.9% sodium chloride injection

MAX INFUSION RATE: Physicians can make dosage adjustments based on achievement and maintenance of each patient’s therapeutic goals.

STORAGE REQUIREMENTS: Refrigerate vials at 2–8°C (36–46°F). Do not freeze. Protect from light.

OTHER WEBSITES: vpriv.com, OnePath.com